Maxygen's Death

Maxygen raised a round of funding on June 04, 2013. Investors include Dead.

Maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs. The company's lead program, MAXY-G34, is designed to be an improved version of long-acting G-CSF for th…

Articles about Maxygen's Death: